BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21633955)

  • 1. ABO blood group and breast cancer incidence and survival.
    Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
    Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
    Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
    Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group and the risk of pancreatic cancer.
    Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
    J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).
    Markt SC; Shui IM; Unger RH; Urun Y; Berg CD; Black A; Brennan P; Bueno-de-Mesquita HB; Gapstur SM; Giovannucci E; Haiman C; Henderson B; Hoover RN; Hunter DJ; Key TJ; Khaw KT; Canzian F; Larranga N; Le Marchand L; Ma J; Naccarati A; Siddiq A; Stampfer MJ; Stattin P; Stevens VL; Stram DO; Tjønneland A; Travis RC; Trichopoulos D; Ziegler RG; Lindstrom S; Kraft P; Mucci LA; Choueiri TK; Wilson KM
    Prostate; 2015 Nov; 75(15):1677-81. PubMed ID: 26268879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
    Mao Y; Yang W; Qi Q; Yu F; Wang T; Zhang H; Dai J; Ma H; Hu Z; Shen H; Li G; Jin G
    BMC Cancer; 2019 Feb; 19(1):164. PubMed ID: 30791881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.
    Tao B; Yang M; Chen H; Pan H; Liu W; Yi H; Tang S
    J Clin Pharm Ther; 2020 Aug; 45(4):638-645. PubMed ID: 32259340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.
    Yu J; Gao F; Klimberg VS; Margenthaler JA
    Ann Surg Oncol; 2012 Oct; 19(10):3159-64. PubMed ID: 22878611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans.
    Shim HJ; Lee R; Shin MH; Kim HN; Cho D; Ahn HR; Kweon SS
    Asian Pac J Cancer Prev; 2015; 16(7):2771-5. PubMed ID: 25854361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
    CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
    Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
    Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
    Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.
    Rummel S; Shriver CD; Ellsworth RE
    BMC Med Genet; 2012 May; 13():41. PubMed ID: 22642827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO blood group and incidence of epithelial ovarian cancer.
    Gates MA; Wolpin BM; Cramer DW; Hankinson SE; Tworoger SS
    Int J Cancer; 2011 Jan; 128(2):482-6. PubMed ID: 20309936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
    Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
    Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO genotype and risk of thrombotic events and hemorrhagic stroke.
    Wiggins KL; Smith NL; Glazer NL; Rosendaal FR; Heckbert SR; Psaty BM; Rice KM; Lumley T
    J Thromb Haemost; 2009 Feb; 7(2):263-9. PubMed ID: 19036074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO blood type is associated with endometrial cancer risk in Chinese women.
    Xu WH; Zheng W; Xiang YB; Shu XO
    Chin J Cancer; 2011 Nov; 30(11):766-71. PubMed ID: 22035857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood group and incidence of skin cancer.
    Xie J; Qureshi AA; Li Y; Han J
    PLoS One; 2010 Aug; 5(8):e11972. PubMed ID: 20694147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 controls.
    Miao SY; Zhou W; Chen L; Wang S; Liu XA
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):101-8. PubMed ID: 23714093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
    Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
    Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
    Poole EM; Gates MA; High BA; Chanock SJ; Cramer DW; Cunningham JM; Fridley BL; Gayther SA; Goode EL; Iversen ES; Lissowska J; Palmieri Weber RT; Pharoah PD; Phelan CM; Ramus SJ; Schildkraut JM; Sutphen R; Tsai YY; Tyrer J; Vierkant RA; Wentzensen N; Yang HP; Terry KL; Tworoger SS
    Cancer Causes Control; 2012 Nov; 23(11):1805-10. PubMed ID: 22961099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.